Sunshine Biopharma Inc
SBFM
View Detailed Chart
1.200USD
+0.050+4.35%
Close 02/06, 16:00（ET）Quotes delayed by 15 min
5.47MMarket Cap
0.23P/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
+4.35%
5 Days
-1.64%
1 Month
-14.89%
6 Months
-14.29%
Year to Date
-2.44%
1 Year
-52.00%
View Detailed Chart
TradingKey Stock Score of Sunshine Biopharma Inc
Currency: USD Updated: 2026-02-06Key Insights
Sunshine Biopharma Inc's fundamentals are relatively very healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 110 out of 159 in the Pharmaceuticals industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 6.00.In the medium term, the stock price is expected to trend down.Despite a weak stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Sunshine Biopharma Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Positive
Sunshine Biopharma Inc Highlights
StrengthsRisks
Sunshine Biopharma Inc. is a pharmaceutical company engaged in offering and researching life-saving medicines in a variety of therapeutic areas, including oncology and antivirals. The Company has approximately 70 generic prescription drugs on the market in Canada. In addition, the Company is conducting a proprietary drug development program which is comprised of K1.1 mRNA, an mRNA-Lipid Nanoparticle targeted for liver cancer, and PLpro protease inhibitor, a small molecule for the treatment of SARS Coronavirus infections. The Company operates through two segments: Prescription Generic Pharmaceuticals (Generic Pharmaceuticals) and Nonprescription Over-The-Counter Products (OTC Products). The Company operates two wholly owned subsidiaries: Nora Pharma Inc., which has a portfolio of pharmaceutical products consisting of various prescription drugs on the market in Canada, and Sunshine Biopharma Canada Inc., which develops and sells nonprescription over-the-counter (OTC) products.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 702.52% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 34.87M.
Overvalued
The company’s latest PE is 0.23, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 370.31K shares, decreasing 26.68% quarter-over-quarter.
Held by James Simons
Star Investor James Simons holds 55.70K shares of this stock.
Analyst Rating
Based on
1
analysts
Buy
Current Rating
6.000
Target Price
+421.74%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Sunshine Biopharma Inc News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Sunshine Biopharma Inc Info
Sunshine Biopharma Inc. is a pharmaceutical company engaged in offering and researching life-saving medicines in a variety of therapeutic areas, including oncology and antivirals. The Company has approximately 70 generic prescription drugs on the market in Canada. In addition, the Company is conducting a proprietary drug development program which is comprised of K1.1 mRNA, an mRNA-Lipid Nanoparticle targeted for liver cancer, and PLpro protease inhibitor, a small molecule for the treatment of SARS Coronavirus infections. The Company operates through two segments: Prescription Generic Pharmaceuticals (Generic Pharmaceuticals) and Nonprescription Over-The-Counter Products (OTC Products). The Company operates two wholly owned subsidiaries: Nora Pharma Inc., which has a portfolio of pharmaceutical products consisting of various prescription drugs on the market in Canada, and Sunshine Biopharma Canada Inc., which develops and sells nonprescription over-the-counter (OTC) products.
Ticker SymbolSBFM
CompanySunshine Biopharma Inc
CEOSlilaty (Steve N)
Websitehttps://www.sunshinebiopharma.com/
Related Instruments
+3.63%
+3.17%
+0.93%
+1.99%
+1.78%
+1.53%
-0.96%
+4.49%
+2.10%
+10.00%
+2.72%
+4.07%
+1.81%
+4.17%
+0.72%
+1.06%
+2.46%
0.00%
+0.53%
+0.56%Popular Symbols
278.120
+2.210 (+0.80%)
185.410
+13.530 (+7.87%)
69601.180
-368.950 (-0.53%)
282.580
+22.390 (+8.61%)
2102.820
+51.090 (+2.49%)
411.110
+13.900 (+3.50%)
4952.980
+142.360 (+2.96%)
63.303
+0.206 (+0.33%)
1.182
+0.004 (+0.35%)
157.098
+0.057 (+0.04%)
